Relative Recirculation: A Fast, Model-Free Surrogate for the Measurement of Blood-Brain Barrier Permeability and the Prediction of Hemorrhagic Transformation in Acute Ischemic Stroke
暂无分享,去创建一个
David J. Mikulis | Andrea Kassner | Rebecca E. Thornhill | D. Mikulis | A. Kassner | R. Thornhill | Shuo Chen | Shuo Chen | Shengping Wu | Wael Rammo | Shengping Wu | W. Rammo
[1] Raimund Erbel,et al. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. , 2009, Journal of the American College of Cardiology.
[2] W P Dillon,et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.
[3] D. Burggraf,et al. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia , 2003, Thrombosis and Haemostasis.
[4] T. Steger-Hartmann,et al. Impact of Renal Impairment on Long-Term Retention of Gadolinium in the Rodent Skin Following the Administration of Gadolinium-Based Contrast Agents , 2009, Investigative radiology.
[5] M. Kaste,et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.
[6] D. Lawrence,et al. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. , 2003, The Journal of clinical investigation.
[7] Scott Hamilton,et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials , 2004, The Lancet.
[8] D. Kent,et al. Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset? , 2003, Stroke.
[9] Andrea Kassner,et al. Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. , 2005, AJNR. American journal of neuroradiology.
[10] Jeffry R Alger,et al. Prediction of hemorrhagic transformation after recanalization therapy using T2*‐permeability magnetic resonance imaging , 2007, Annals of neurology.
[11] Hai-Ling Margaret Cheng,et al. Investigation and optimization of parameter accuracy in dynamic contrast‐enhanced MRI , 2008, Journal of magnetic resonance imaging : JMRI.
[12] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] T. Miyati,et al. Dual dynamic contrast‐enhanced MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[14] B. D. Ward,et al. Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation , 2005, Magnetic resonance in medicine.
[15] B. Rosen,et al. Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.
[16] T. N. t-P. S. S. Group,et al. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. , 1997, Stroke.
[17] H. Thomsen,et al. High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent , 2008, Investigative radiology.
[18] G. Hamann,et al. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. , 1995, Stroke.
[19] M. Wintermark,et al. Dynamic Perfusion CT Assessment of the Blood-Brain Barrier Permeability: First Pass versus Delayed Acquisition , 2008, American Journal of Neuroradiology.
[20] V. Runge,et al. Nephrogenic Systemic Fibrosis: A Review of 6 Cases Temporally Related to Gadodiamide Injection (Omniscan) , 2007, Investigative radiology.
[21] C. Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] Susan M. Chang,et al. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. , 2005, AJNR. American journal of neuroradiology.
[23] A. Jackson,et al. Abnormalities of the contrast re‐circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast‐enhanced imaging: A possible marker of vascular tortuosity , 2000, Journal of magnetic resonance imaging : JMRI.
[24] G. Hamann,et al. Hemorrhagic Transformation of Cerebral Infarction – Possible Mechanisms , 1999, Thrombosis and Haemostasis.
[25] T. Frenzel,et al. A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast Media , 2008, Investigative radiology.
[26] Hartmut H. Malluche,et al. Food and Drug Administration Center for Drug Evaluation and Research , 1996 .
[27] K. Furie,et al. Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke , 2004, Stroke.
[28] J L Evelhoch,et al. Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.
[29] Max Wintermark,et al. Imaging of intracranial haemorrhage , 2008, The Lancet Neurology.
[30] Steven Warach,et al. Early blood–brain barrier disruption in human focal brain ischemia , 2004, Annals of neurology.
[31] R. Knight,et al. Step-down infusions of Gd-DTPA yield greater contrast-enhanced magnetic resonance images of BBB damage in acute stroke than bolus injections. , 2007, Magnetic resonance imaging.
[32] Glyn Johnson,et al. Measuring blood volume and vascular transfer constant from dynamic, T 2* ‐weighted contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.
[33] Alan Jackson,et al. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. , 2002, AJNR. American journal of neuroradiology.